Kayla Bergeron laughs with a resident of Connection Forsyth, an addiction recovery support center, where she works as a mentor in Cumming, Georgia, U.S., July 1, 2021. REUTERS/Shannon Stapleton SEARCH "SEPTEMBER 11 WITNESS" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES.

A demonstrator carries a sign that reads "Fear - vaccination - addiction" during a protest against the government's coronavirus disease (COVID-19) restrictions in Stuttgart, Germany, April 3, 2021. REUTERS/Andreas Gebert

Patrick Fitzgerald listens as Purdue Chairman Steve Miller enters a guilty plea on the company's behalf during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. REUTERS/Jane Rosenberg

Stephen Forketic listens as Purdue Chairman Steve Miller enters a guilty plea on the company's behalf during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. REUTERS/Jane Rosenberg

The guilty plea from Purdue is shown on screen during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. REUTERS/Jane Rosenberg

U.S. District Judge Madeline Cox Arleo listens as Purdue Chairman Steve Miller enters a guilty plea on the company's behalf during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. REUTERS/Jane Rosenberg

Purdue Chairman Steve Miller (top, 2nd R) enters a guilty plea on the company's behalf during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. The others on screen are Patrick Fitzgerald, Andrew Muscato, Sean Sherman, U.S. District Judge Madeline Cox Arleo and Stephen Forketic. REUTERS/Jane Rosenberg

Purdue Chairman Steve Miller enters a guilty plea on the company's behalf during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. The others on screen are Sean Sherman, U.S. District Judge Madeline Cox Arleo and Stephen Forketic. REUTERS/Jane Rosenberg

Purdue Chairman Steve Miller (top R) enters a guilty plea on the company's behalf during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. The others on screen are Patrick Fitzgerald, Andrew Muscato and U.S. District Judge Madeline Cox Arleo. REUTERS/Jane Rosenberg

Purdue Chairman Steve Miller enters a guilty plea on the company's behalf during a court hearing over the handling of Purdue Pharma LP's addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker's role in the U.S. opioid crisis, in this courtroom sketch of the remote Newark, New Jersey, U.S., court hearing on November 24, 2020. REUTERS/Jane Rosenberg

Deputy U.S. Attorney General Jeffrey Rosen announces that Purdue Pharma LP has agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin during a news conference at the Justice Department in Washington, U.S., October 21, 2020. REUTERS/Yuri Gripas/Pool

Acting Assistant U.S. Attorney General Jeffrey Clark speaks next to Deputy U.S. Attorney General Jeffrey Rosen at a news conference, where they announced that Purdue Pharma LP has agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, at the Justice Department in Washington, U.S., October 21, 2020. REUTERS/Yuri Gripas/Pool

Deputy U.S. Attorney General Jeffrey Rosen removes his face mask as he announces that Purdue Pharma LP has agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin during a news conference at the Justice Department in Washington, U.S., October 21, 2020. REUTERS/Yuri Gripas/Pool

Deputy U.S. Attorney General Jeffrey Rosen announces that Purdue Pharma LP has agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin during a news conference at the Justice Department in Washington, U.S., October 21, 2020. REUTERS/Yuri Gripas/Pool

Deputy U.S. Attorney General Jeffrey Rosen announces that Purdue Pharma LP has agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin during a news conference at the Justice Department in Washington, U.S., October 21, 2020. REUTERS/Yuri Gripas/Pool

Deputy U.S. Attorney General Jeffrey Rosen announces that Purdue Pharma LP has agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin during a news conference at the Justice Department in Washington, U.S., October 21, 2020. REUTERS/Yuri Gripas/Pool

A combination of file photos shows U.S. Senator Ron Johnson (R-WI) during the Senate Homeland Security and Governmental Affairs Committee in Washington, U.S., August 6, 2020, Senator Thom Tillis (R-NC) during a Senate Judiciary Committee hearing in Washington, U.S., June 16, 2020, Senator Mike Lee (R-UT) during a Senate Judiciary Committee hearing in Washington, U.S., June 2, 2020, U.S. first lady Melania Trump hosting an Indian Health Service (IHS) Task Force briefing at the White House in Washington, U.S., July 23, 2020, White House senior adviser Kellyanne Conway during a press briefing at the White House in Washington, U.S., January 30, 2020, then New Jersey Governor Chris Christie taking part in the President's Commission on Combating Drug Addiction and the Opioid Crisis in Washington, U.S., June 16, 2017, Republican National Committee Chairman Ronna McDaniel during the largely virtual 2020 Republican National Convention in Washington, U.S., August 24, 2020, Hope Hicks, communication director for U.S. Republican presidential candidate Donald Trump, following a news conference at Trump Tower in the Manhattan borough of New York, U.S., May 31, 2016, White House policy advisor Stephen Miller at a round table meeting in the White House in Washington, U.S., March 20, 2018, and White House Press Secretary Kayleigh McEnany at the Republican National Convention from the Mellon Auditorium in Washington, U.S., August 26, 2020. Tom Williams/Toni Sandys/Pool via REUTERS and REUTERS/Yuri Gripas/Joshua Roberts/Kevin Lamarque/Jonathan Ernst/Carlo Allegri/Tom Brenner/Leah Millis/File Photo

A combination of file photos shows U.S. Senator Ron Johnson (R-WI) during the Senate Homeland Security and Governmental Affairs Committee in Washington, U.S., August 6, 2020, Senator Thom Tillis (R-NC) during a Senate Judiciary Committee hearing in Washington, U.S., June 16, 2020, Senator Mike Lee (R-UT) during a Senate Judiciary Committee hearing in Washington, U.S., June 2, 2020, U.S. first lady Melania Trump hosting an Indian Health Service (IHS) Task Force briefing at the White House in Washington, U.S., July 23, 2020, White House senior adviser Kellyanne Conway during a press briefing at the White House in Washington, U.S., January 30, 2020, Governor Chris Christie of New Jersey taking part in the President's Commission on Combating Drug Addiction and the Opioid Crisis in Washington, U.S., June 16, 2017, Republican National Committee Chairman Ronna McDaniel during the largely virtual 2020 Republican National Convention in Washington, U.S., August 24, 2020 and Hope Hicks, communication director for U.S. Republican presidential candidate Donald Trump, following a news conference at Trump Tower in the Manhattan borough of New York, U.S., May 31, 2016. Tom Williams/Toni Sandys/Pool via REUTERS and REUTERS/Yuri Gripas/Joshua Roberts/Kevin Lamarque/Jonathan Ernst/Carlo Allegri

Patients sit at the Habeeb Habeeb Mental Health Hospital where they deal with khat addiction in Waberi district of Mogadishu, Somalia June 23, 2020. Picture taken June 23, 2020. REUTERS/Feisal Omar

A doctor reviews a patient at the Habeeb Mental health hospital where they deal with khat addiction in Waberi district of Mogadishu, Somalia June 23, 2020. Picture taken June 23, 2020. REUTERS/Feisal Omar

A doctor reviews a patient at the Habeeb Mental health hospital where they deal with khat addiction in Waberi district of Mogadishu, Somalia June 23, 2020. Picture taken June 23, 2020. REUTERS/Feisal Omar

A doctor reviews a patient at the Habeeb Mental health hospital where they deal with khat addiction in Waberi district of Mogadishu, Somalia June 23, 2020. Picture taken June 23, 2020. REUTERS/Feisal Omar

A woman demonstrates how the mySafe narcotic dispensing machine uses a palm-print ID at the Overdose Prevention Society as the local health unit has begun prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to entice addicts and homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

General view of a homeless encampment at Vancouver's Oppenheimer Park as the local health unit has started prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to entice addicts and homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

People gather along East Hastings Street as the local health unit has begun prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

People gather along East Hastings street as the local health unit has started prescribing a "safe supply" of opioid alternatives to combat overdoses due to poisonous additives and to entice addicts and homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

Chrissy McMullin displays her "safe supply" of opioid alternative Dilaudid, provided by the local health unit to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

Chrissy Mullins obtained a "safe supply" of opioid alternatives, provided by the local health unit to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

People sit ner a homeless encampment at Oppenheimer Park as the local health unit has started prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

A man injects street drugs in an alley in Vancouver's Downtown Eastside as the local health unit has begun prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to help support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

A woman wearing a protective mask walks through an alley in Vancouver's Downtown Eastside as the local health unit has begun prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

Brent Marriott (left) obtained a "safe supply" of opioid alternatives, provided by the local health unit to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

Chrissy McMullin, who is reliant on opioid drugs, poses for a portrait in Vancouver's Crabb Park as the local health unit has begun prescribing a "safe supply" of opioid alternatives to combat overdoses due to poisonous additives and to help support addicts like McMullin in practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

Angel Gates waits in her single room occupancy apartment for a call from the local health unit, hoping to obtain a "safe supply" of narcotic alternatives being prescribed to combat overdoses due to poisonous additives and to entice addicts and homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

An intravenous (IV) drug user fills a syringe with street drugs in Vancouver's Downtown Eastside as the local health unit has started providing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to help support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

An ambulance drives through downtown Vancouver as the local health unit has started prescribing a "safe supply" of opioid alternatives to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

A front line worker from Portland Hotel Society healthcare checks on clients waiting to obtain a "safe supply" of narcotic alternatives, provided by the local health unit to combat overdoses due to poisonous additives and to help supports addicts and homeless in practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

Angel Gates (centre) waits in line outside a local health clinic hoping to obtain a "safe supply" of stimulant drugs, provided by the local health unit to combat overdoses due to poisonous additives and to help support addicts and the homeless in practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

The mySafe narcotic dispensing machine is seen at the Overdose Prevention Society as Vancouver's local health unit has begun prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to entice addicts and homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 7, 2020. REUTERS/Jesse Winter

A fentanyl user displays a "safe supply" of opioid alternatives, including morphine pills, provided by the local health unit to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

A fentanyl user displays a "safe supply" of opioid alternatives, provided by the local health unit to combat overdoses due to poisonous additives and to support addicts and the homeless in practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 6, 2020. Picture taken April 6, 2020. REUTERS/Jesse Winter

Peer support worker Thomus Donaghy adjusts his protective mask outside the Molson Overdose prevention site as the local health unit has begun prescribing a "safe supply" of narcotic alternatives to combat overdoses due to poisonous additives and to support addicts and the homeless into practicing social distancing to help slow the spread of coronavirus disease (COVID-19) in the Downtown Eastside of Vancouver, British Columbia, Canada April 7, 2020. Picture taken April 7, 2020. REUTERS/Jesse Winter

A recovered drug addict reads the Bible before being released from the Mega Drug Abuse Treatment and Rehabilitation Center, in Nueva Ecija province, north of Manila, Philippines December 9, 2019. Picture taken December 9, 2019. REUTERS/Eloisa Lopez

Frank Huntley looks at his sculpture made out of the opioid pill bottles he got when addicted, set up outside Democratic presidential candidate and former Vice President Joe Biden's campaign event in Somersworth, New Hampshire, U.S., February 5, 2020. REUTERS/Rick Wilking

Packages of seized drugs are pictured at the Bolivian police headquarters after operations against drug trafficking in La Paz, Bolivia January 23, 2020. REUTERS/David Mercado

People have meals during a charity event to distribute food among lower-income citizens in a cathedral compound in Stavropol, Russia December 13, 2019. The event was organized by clergymen and social activists as the food was cooked by volunteers including former drug and alcohol addicts. REUTERS/Eduard Korniyenko

People have meals during a charity event to distribute food among lower-income citizens in a cathedral compound in Stavropol, Russia December 13, 2019. The event was organized by clergymen and social activists as the food was cooked by volunteers including former drug and alcohol addicts. REUTERS/Eduard Korniyenko

People have meals during a charity event to distribute food among lower-income citizens in a cathedral compound in Stavropol, Russia December 13, 2019. The event was organized by clergymen and social activists as the food was cooked by volunteers including former drug and alcohol addicts. REUTERS/Eduard Korniyenko

People have meals during a charity event to distribute food among lower-income citizens in a cathedral compound in Stavropol, Russia December 13, 2019. The event was organized by clergymen and social activists as the food was cooked by volunteers including former drug and alcohol addicts. REUTERS/Eduard Korniyenko

An elderly woman has a meal during a charity event to distribute food among lower-income citizens in a cathedral compound in Stavropol, Russia December 13, 2019. The event was organized by clergymen and social activists as the food was cooked by volunteers including former drug and alcohol addicts. REUTERS/Eduard Korniyenko

William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings, sits for an interview with Reuters in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor

William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings, poses for a portrait at his home in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor

William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings, does homework at his home in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor

Kristen Smith - mother of William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings - is interviewed by Reuters in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor

William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings, poses for a portrait at his home in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor

William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings, and his mother Kristen Smith are interviewed by Reuters in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor

William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings, sits for an interview with Reuters in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor

William Smith, a 17 year-old high school senior who was addicted to Juul for more than a year leading to near-failing grades and wild mood swings, poses for a portrait at his home in Newburyport, Massachusetts, U.S., October 8, 2019. Picture taken October 8, 2019. To match Special Report JUUL-ECIGARETTE/ REUTERS/Katherine Taylor